Travelers stock rating prices target

Travelers stock rating prices target : TheStreet reissued their buy rating on shares of The Travelers Companies (NYSE: TRV) in a report released on Monday, StockRatingsNetwork reports. “Travelers Companies (TRV) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.” ,” the firm’s analyst commented.


The Travelers Companies (NYSE: TRV) traded down 1.89% on Monday, hitting $84.91. The Travelers Companies has a 52-week low of $59.40 and a 52-week high of $86.61. The stock’s 50-day moving average is currently $83.10. The company has a market cap of $32.092 billion and a price-to-earnings ratio of 13.75.

TRV has been the subject of a number of other recent research reports. Analysts at Evercore Partners reiterated an equal weight rating on shares of The Travelers Companies in a research note to investors on Thursday, April 11th. They now have a $87.00 price target on the stock. Separately, analysts at Sandler O’Neill raised their price target on shares of The Travelers Companies from $89.00 to $95.00 in a research note to investors on Tuesday, April 9th. Finally, analysts at Credit Suisse raised their price target on shares of The Travelers Companies from $95.00 to $100.00 in a research note to investors on Tuesday, April 9th. They now have an outperform rating on the stock.

Nine investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. The Travelers Companies has a consensus rating of Buy and a consensus price target of $85.27.

The Travelers Companies, Inc. (NYSE: TRV) is a holding company.

0 comments:

Post a Comment

Related Post